Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 36  Show
  1. 1
    "Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3."
    Dammann R., Li C., Yoon J.-H., Chin P.L., Bates S., Pfeifer G.P.
    Nat. Genet. 25:315-319(2000) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; B AND C), FUNCTION, TISSUE SPECIFICITY, VARIANT GLN-21, INTERACTION WITH XPA.
    Category: Function, Expression, Interaction, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  2. 2
    Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A; C; D; E; F AND G), FUNCTION, TISSUE SPECIFICITY, VARIANTS GLN-21; CYS-53; GLU-133; SER-137 AND CYS-329.
    Category: Function, Expression, Sequences.
    Tissue: Heart, Lung and Pancreas.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  3. 3
    "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."
    Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A.
    Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM C).
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  4. 4
    "The DNA sequence, annotation and analysis of human chromosome 3."
    Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J.
    Gibbs R.A.
    Nature 440:1194-1198(2006) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 3896 other entries.

  5. 5
    Category: Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).
  6. 6
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND B).
    Category: Sequences.
    Tissue: Blood and Brain.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50448 other entries.

  7. 7
    "The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation."
    Shivakumar L., Minna J., Sakamaki T., Pestell R., White M.A.
    Mol. Cell. Biol. 22:4309-4318(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, VARIANT PHE-135, CHARACTERIZATION OF VARIANTS PHE-135 AND SER-137.
    Category: Function, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 4 other entries.

  8. 8
    "The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1."
    Ortiz-Vega S., Khokhlatchev A., Nedwidek M., Zhang X.F., Dammann R., Pfeifer G.P., Avruch J.
    Oncogene 21:1381-1390(2002) [PubMed] [Europe PMC] [Abstract]
    Cited for: SELF-ASSOCIATION, INTERACTION WITH RSSF5 AND HRAS.
    Category: Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 and mapped to 8 other entries.

  9. 9
    "Identification of the E1A-regulated transcription factor p120 E4F as an interacting partner of the RASSF1A candidate tumor suppressor gene."
    Fenton S.L., Dallol A., Agathanggelou A., Hesson L., Ahmed-Choudhury J., Baksh S., Sardet C., Dammann R., Minna J.D., Downward J., Maher E.R., Latif F.
    Cancer Res. 64:102-107(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH E4F1.
    Category: Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 and mapped to 3 other entries.

  10. 10
    "RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics."
    Dallol A., Agathanggelou A., Fenton S.L., Ahmed-Choudhury J., Hesson L., Vos M.D., Clark G.J., Downward J., Maher E.R., Latif F.
    Cancer Res. 64:4112-4116(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH MAP1S.
    Category: Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  11. 11
    "The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex."
    Song M.S., Song S.J., Ayad N.G., Chang J.S., Lee J.H., Hong H.K., Lee H., Choi N., Kim J., Kim H., Kim J.W., Choi E.-J., Kirschner M.W., Lim D.-S.
    Nat. Cell Biol. 6:129-137(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH CDC20.
    Category: Function, Subcellular Location, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 3 other entries.

  12. 12
    "Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras."
    Praskova M., Khoklatchev A., Ortiz-Vega S., Avruch J.
    Biochem. J. 381:453-462(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, INTERACTION WITH STK3/MST2 AND STK4/MST1.
    Category: Function, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 and mapped to 1 other entries.

  13. 13
    "Specificity of the methylation-suppressed A isoform of candidate tumor suppressor RASSF1 for microtubule hyperstabilization is determined by cell death inducer C19ORF5."
    Liu L., Vo A., McKeehan W.L.
    Cancer Res. 65:1830-1838(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH MAP1S.
    Category: Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  14. 14
    "The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death."
    Baksh S., Tommasi S., Fenton S., Yu V.C., Martins L.M., Pfeifer G.P., Latif F., Downward J., Neel B.G.
    Mol. Cell 18:637-650(2005) [PubMed] [Europe PMC] [Abstract]
    Cited for: INTERACTION WITH MOAP1, FUNCTION.
    Category: Function, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 other entry.

  15. 15
    Cited for: FUNCTION, INTERACTION WITH STK3/MST2 AND STK4/MST1.
    Category: Function, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 other entries.

  16. 16
    "The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex."
    Song M.S., Song S.J., Kim S.Y., Oh H.J., Lim D.S.
    EMBO J. 27:1863-1874(2008) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, IDENTIFICATION IN A COMPLEX WITH MDM2; DAXX AND USP7, INTERACTION WITH DAXX AND MDM2, SUBCELLULAR LOCATION.
    Category: Function, Subcellular Location, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 3 and mapped to 18 other entries.

  17. 17
    Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS], IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: PTM / Processing, Sequences.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1399 other entries.

  18. 18
    "The tumor suppressor RASSF1A prevents dephosphorylation of the mammalian STE20-like kinases MST1 and MST2."
    Guo C., Zhang X., Pfeifer G.P.
    J. Biol. Chem. 286:6253-6261(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: FUNCTION, INTERACTION WITH STK3/MST2 AND STK4/MST1.
    Category: Function, Interaction.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2 and mapped to 7 other entries.

  19. 19
    Cited for: METHYLATION [LARGE SCALE ANALYSIS] AT ARG-36, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
    Category: PTM / Processing, Sequences.
    Tissue: Colon carcinoma.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 2037 other entries.

  20. 20
    "Structural characterization of the DAXX N-terminal helical bundle domain and its complex with Rassf1C."
    Escobar-Cabrera E., Lau D.K., Giovinazzi S., Ishov A.M., McIntosh L.P.
    Structure 18:1642-1653(2010) [PubMed] [Europe PMC] [Abstract]
    Cited for: STRUCTURE BY NMR (ISOFORM C/H) IN COMPLEX WITH DAXX.
    Category: Interaction, Structure.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 and mapped to 6 other entries.

  21. 21
    "Substrate specificities and identification of putative substrates of ATM kinase family members."
    Kim S.-T., Lim D.-S., Canman C.E., Kastan M.B.
    J. Biol. Chem. 274:37538-37543(1999) [PubMed] [Europe PMC] [Abstract]
    Category: PTM / Processing.
    Source: PhosphoSitePlus:Q9NS23.

    This publication is mapped to 8 other entries.

  22. 22
    "A protein interaction framework for human mRNA degradation."
    Lehner B., Sanderson C.M.
    Genome Res. 14:1315-1323(2004) [PubMed] [Europe PMC] [Abstract]
    Category: Interaction.
    Source: IntAct:Q9NS23.

    This publication is cited by 9 and mapped to 181 other entries.

  23. 23
    "A polymorphism at codon 133 of the tumor suppressor RASSF1A is associated with tumorous alteration of the breast."
    Schagdarsurengin U., Seidel C., Ulbrich E.J., Kolbl H., Dittmer J., Dammann R.
    Int. J. Oncol. 27:185-191(2005) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Annotation: Associated with CANCER: breast cancer.
    Source: GAD:133624.

    This publication is mapped to 4 other entries.

  24. 24
    "Single nucleotide polymorphism at codon 133 of the RASSF1 gene is preferentially associated with human lung adenocarcinoma risk."
    Kanzaki H., Hanafusa H., Yamamoto H., Yasuda Y., Imai K., Yano M., Aoe M., Shimizu N., Nakachi K., Ouchida M., Shimizu K.
    Cancer Lett. 238:128-134(2006) [PubMed] [Europe PMC] [Abstract]
    Category: Pathology & Biotech.
    Annotation: Associated with CANCER: lung cancer; colorectal cancer; esophageal cancer; head and neck cancer.
    Source: GAD:133625.

    This publication is mapped to 4 other entries.

  25. 25
    Category: Interaction.
    Source: IntAct:Q9NS23.

    This publication is mapped to 1656 other entries.

1 to 25 of 36  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again